中國中車(01766.HK)擬使用不超200億元自有資金購買低風險理財產品
格隆匯3月30日丨中國中車(01766.HK)公佈,公司於2020年3月30日召開了第二屆董事會第十七次會議,審議通過了《關於中國中車股份有限公司及下屬上市公司購買理財產品的議案》。為進一步提高公司資金使用效益,增加公司現金資產收益,實現股東利益最大化,公司擬在確保資金安全、操作合法合規、保證正常生產經營不受影響並有效控制投資風險的前提下,使用總額不超過人民幣200億元的自有資金購買低風險理財產品(不用於投資股票及衍生產品),在該額度內,資金可以滾動使用。同時,公司董事會授權公司總裁具體實施理財相關事宜,授權期限自本次董事會審議通過日起至2021年3月31日有效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.